PHILADELPHIA, Feb. 16, 2012 /PRNewswire/ -- Premier Research Group Limited announces the opening of new state-of-the-art clinical research facilities located in Phoenix and Salt Lake City, increasing their testing facilities capacity by 50%.
"We are excited to be expanding our existing clinical research facilities to accommodate more phase 1 and outpatient studies," stated Michael Kuss, Vice President, Analgesia. "These new facilities give us the capability to reach and house more study volunteers as well as successfully conduct phase 2 and 3 chronic pain, migraine, dysmenorrhea, vaccine, obesity and other models at all our sites."
In addition to the full service CRO offerings, Premier Research owns and operates a network of clinical research centers designed to offer clinical site services from phase 1 proof of concept trials to phase 4 post-marketing trials primarily in the areas of healthy normal volunteers, acute and chronic pain, rheumatology, and neuroscience. Each of the centers has multiple experienced investigators and full-time Premier Research staff that are medically trained and highly experienced.
Premier Research has been in the Phoenix market since 1993 and in Salt Lake City since 1999. The Phoenix site is located in the Deer Valley Medical Center at 20414 N. 27th Avenue, Suite 200, and the Salt Lake City center is located at 3995 South 700 East #250.
About Premier Research
Premier Research is a professional services company providing clinical development support to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide. The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it has grown a strong strategic sourcing group that supports customers in their resource planning and management.
The company offers a comprehensive series of services for every phase of clinical development including regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.
For more information please visit, www.premier-research.com.
SOURCE Premier Research Group